Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-11T19:57:25.106Z Has data issue: false hasContentIssue false
  • English
  • Français

Hybrid perventricular muscular ventricular septal defect closure using the new multi-functional occluder

Published online by Cambridge University Press:  13 August 2020

Raymond N. Haddad Open the ORCID record for Raymond N. Haddad [Opens in a new window] ,
Régis Gaudin ,
Damien Bonnet Open the ORCID record for Damien Bonnet [Opens in a new window]  and
Sophie Malekzadeh-Milani Open the ORCID record for Sophie Malekzadeh-Milani [Opens in a new window]
Raymond N. Haddad*
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
Régis Gaudin
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
Damien Bonnet
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
Sophie Malekzadeh-Milani
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
*
Author for correspondence: Dr. Raymond N. Haddad, MD, Unité médico-chirurgicale de cardiologie congénitale et pédiatrique, centre de référence des malformations cardiaques congénitales complexes – M3C, Hôpital universitaire Necker-Enfants malades, 149, rue de Sèvres, Paris750015, France. Tel: +33 7 53 15 95 04, +961 70 605 800; Fax: +33 1 44 49 47 30. E-mail: raymondhaddad@live.com
Get access Rights & Permissions [Opens in a new window]

Abstract

The hybrid perventricular approach for the closure of trabecular ventricular septal defects is an attractive treatment modality for small children. Worldwide experience has shown that procedure success is influenced by the defect anatomical accessibility, operators’ expertise, and device technical features. In May 2018, a new promising device, the KONAR-Multi-functional™ ventricular septal defect occluder (Lifetech, Shenzhen, China), obtained CE-marking for septal defect transcatheter closure after the first-in-man implantation in 2013. Herein, this is the first report of successful perventricular closure of ventricular septal defect using this new device in a child with significant co-morbidities.

Keywords

Ventricular septal defectcardiac catheterisationdevice closureperventricularmulti-functional occluder
Type
Brief Report
Information
Cardiology in the Young , Volume 30 , Issue 10 , October 2020 , pp. 1517 - 1520
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Zhu, D, Tao, K, An, Q, Luo, S, Gan, C, Lin, K. Perventricular device closure of residual muscular ventricular septal defects after repair of complex congenital heart defects in pediatric patients. Tex Heart Inst J 2013; 40: 534–540.Google ScholarPubMed
Gray, RG, Menon, SC, Johnson, JT, et al. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: a multicenter PICES investigation. Catheter Cardiovasc Interv 2017; 90: 281–289. doi: 10.1002/ccd.27121.CrossRefGoogle ScholarPubMed
Schubert, S, Kelm, M, Koneti, NR, Berger, F. First European experience of percutaneous closure of ventricular septal defects using a new CE-marked VSD occluder. EuroIntervention 2019; 15: e242–e243. doi: 10.4244/EIJ-D-18-00867.CrossRefGoogle ScholarPubMed
Haddad, RN, Daou, LS, Saliba, ZS. Percutaneous closure of restrictive-type perimembranous ventricular septal defect using the new KONAR multifunctional occluder: midterm outcomes of the first middle-eastern experience. Catheter Cardiovasc Interv 2019. doi: 10.1002/ccd.28678.Google ScholarPubMed
Tanidir, IC, Baspinar, O, Saygi, M, Kervancioglu, M, Guzeltas, A, Odemis, E. Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study. Int J Cardiol 2020; 310: 43–50. doi: 10.1016/j.ijcard.2020.02.056.CrossRefGoogle ScholarPubMed
Bearl, DW, Fleming, GA. Utilizing hybrid techniques to maximize clinical outcomes in congenital heart disease. Curr Cardiol Rep 2017; 19: 72. doi: 10.1007/s11886-017-0878-2.CrossRefGoogle ScholarPubMed
Pedra, CA, Pedra, SR, Chaccur, P, et al. Perventricular device closure of congenital muscular ventricular septal defects. Expert Rev Cardiovasc Ther 2010; 8: 663–674. doi: 10.1586/erc.10.31.CrossRefGoogle ScholarPubMed
Yin, S, Zhu, D, Lin, K, An, Q. Perventricular device closure of congenital ventricular septal defects. J Card Surg 2014; 29: 390–400. doi: 10.1111/jocs.12334.CrossRefGoogle ScholarPubMed
Bartel, T, Tuzcu, EM. A hybrid technique for ventricular septal defect closure in young infants. Catheter Cardiovasc Interv 2017; 90: 290–291. doi: 10.1002/ccd.27227.CrossRefGoogle ScholarPubMed